MARATTO

article · Benha Medical Journal

Prevalence and Quality of Life Among Children with Mono Symptomatic Nocturnal Enuresis at Benha City, Egypt

2024Open accessBenha University

Abstract

Background: Nocturnal enuresis (NE), is a distressing experience for children and their families, and successful treatment invariably improves their quality of life.Objectives: To quantify the prevalence of mono symptomatic nocturnal enuresis among children attending outpatient family health clinics at Benha city, identification of associated risk factors and to assess their quality of life.Methods: This is a comparative cross-sectional study conducted among children (5-15 years) attending outpatient family health clinics at Benha city. Complete medical examination and a brief questionnaire were distributed to screen the children, after their approval consent to fill a well-designed questionnaire.Results: Prevalence of NE was 16.2 %, statistical analysis showed non-significant difference among studied groups regarding number of brothers, order of birth, parents' occupoation, history of constipation,family history of NE (p>0.05). There was a statistical significant difference among studied groups regarding sex, age, parents' education,socioeconomic level , period of using diapers, and education success and impact QOL (p < 0.05).Conclusion:The frequency of NE declines by aging process. This study suggests that enuretic children have low QoL when compared to non-enuretic ones. This finding reinforces the need of a reliable therapeutic approach early in life, with a multidisciplinary group to prevent them from this loss.

Research topics

  • Urinary Bladder and Prostate Research

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/bmfj.2024.242947.1925

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.